Open Access

Dabigatran reversal in practice.

Topic: Acute intensive cardiovascular care
Sponsored by Boehringer Ingelheim

Presentation

About the speaker

Professor Charles Pollack

VERO Biotech, Atlanta (United States of America)
4 presentations
0 follower

3 more presentations in this session

NOACs: where are we going?

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Thumbnail

Safety, efficacy, security: the new era in anticoagulation care.

Speaker: Professor T. Villines (Charlottesville, US)

Thumbnail

Panel discussion and Q&A: oral anticoagulation + specific reversal = more control.

Speaker: Professor G. Boriani (Modena, IT)

Thumbnail

Access the full session

Oral anticoagulation + specific reversal = more control

Speakers: Professor C. Pollack, Doctor J. Eikelboom, Professor T. Villines, Professor G. Boriani
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

Related content

ESC Premium Access

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

28 August 2021

This platform is supported by

logo Novo Nordisk